Scios And Medtronic To Develop Heart Failure Treatment

. has announced its entry into a research collaboration with Medtronic, Inc. to study the effects of Scios’ investigational agent Natrecor (nesiritide) in combination with Medtronic’s heart failure devices and implantable infusion systems.

“We are excited to establish this collaboration as both Scios and Medtronic have a shared commitment to the diagnosis and management of heart failure in all of its manifestations,” said Scios Chief Scientific Officer George F. Schreiner, M.D., Ph.D. “This research effort between the two companies explores the potential for new heart failure treatments combining Natrecor’s unique therapeutic properties with Medtronic’s approach to the treatment of heart failure.”

In the first of a planned program of pilot clinical studies, the hemodynamic and clinical effects of Natrecor, including the effects on spontaneous activity and controlled exercise tolerance, will be evaluated using information collected by Medtronic’s Chronicle Implantable Hemodynamic Monitor (IHM) both during and after infusions of Natrecor.

The pilot feasibility study is expected to begin this quarter at the Karolinska Hospital in Stockholm.

Both Natrecor and the Chronicle IHM are currently under clinical investigation in the United States.

Natrecor is currently being reviewed by the U.S. FDA as a potential treatment for acute CHF. If approved for marketing by the FDA, Natrecor would be the first new treatment available for acute CHF in over a decade.

The Chronicle system is being studied in a worldwide multicenter clinical trial.

Medtronic expects to file for U.S. and European marketing approvals for this system by the end of this year.

Scios is a biopharmaceutical company developing novel treatments for cardiovascular and inflammatory diseases.

The company’s disease-based technology platform integrates expertise in protein biology with combinatorial and medicinal chemistry to identify novel targets and rationally design large and small-molecule compounds to treat cardiovascular and inflammatory diseases, two of the world’s leading unmet medical needs.

Buy Dragon Pharma LLC Online

Trenbolone 200

Injectable Anabolic Steroid
Base Constituent: Trenbolone Enanthate
Branded by: Dragon Pharma
Amount: 1 X 10 ml (200 mg/ml)

NPP 150 - Cheap Price

Administration: Injection
Main Constituent: Nandrolone Phenylpropionate
Branded by: Dragon Pharma Labs
Package: 20 x 10 mL vial (150 mg/mL)
Price: 20 x $25.00

Trenbolone 50

Injectable Anabolic Steroid
Primary Ingredient: Trenbolone Suspension
Produced by: Dragon Pharma Labs
Amount: 1 X 10 mL vial (50 mg/mL)

Tritren 150

Injectable Steroid for Muscle Growth
Mix of: Trenbolone Acetate,
Trenbolone Enanthate, Trenbolone Hexahydrobenzylcarbonate
Branded by: Dragon Pharmaceuticals
10 mL Sterile Multi-dose Vial (150 mg/mL)

Trenbolone 100 [10 Vials]

Injectable Steroid for Muscle Growth
Basic Chemical Name: Trenbolone Acetate
Manufacturer: Dragon Pharmaceuticals
10 Vials [10 mL per Vial (100 mg/ml)]
Price: 10 x $60.00 = $600.00 in Total

Primobolan 200

Injectable Steroid for Muscle Growth
Principal Substance: Methenolone Enanthate
Branded by: Dragon Pharma Labs
10 mL Sterile Multi-dose Vial (200 mg/mL)

Cypionat 250 [10 Vials]

Injectable Steroid for Muscle Growth
Prime Substance: Testosterone Cypionate
Producer: Dragon Pharma
10 Vials [10 mL per Vial (250 mg/ml)]
Price: 10 x $36.00 = $360.00 in Total

Deca 300 [10 Vials]

Injectable Steroid for Muscle Growth
Basic Ingredient: Nandrolone Decanoate
Made by: Dragon Pharma Labs
10 Vials [10 mL per Vial (300 mg/ml)]
Price: 10 x $45.00 = $450.00 in Total

Masteron 100

Active Substance: Drostanolone Di-Propionate
Producer: Dragon Pharmaceutical
Pack: 10 x 10 mL vial (100 mg/mL)

EQ 500

Basal Ingredient: Boldenone Undecylenate
Manufacturer: Dragon Pharma LLC
Pack: 10 mL vial (500 mg/mL)

1-Test Cyp 200

Basic Component: Dihydroboldenone Cypionate
Produced by: Dragon Pharma
Amount: 10 mL vial (200 mg/mL)

Cut Mix 150 for Sale

Injectable Anabolic Steroid
Main Ingredient: Testosterone Propionate,
Drostanolone Propionate, Trenbolone Acetate
Produced by: Dragon Pharma
Amount: 10 x 10 mL vial (150 mg/mL)
Price per Amount: 52.00 USD